THESEUS PHARMACEUTICALS INC shareholders Q3 2023

THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 64 filers reported holding THESEUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

THESEUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Red Tortoise LLC 536$1,4420.00%
TD ASSET MANAGEMENT INC 213,896$575,3800.00%
Renaissance Technologies 126,194$3390.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 79,751$214,5300.00%
Legal & General Group Plc 1,930$5,1920.00%
GEODE CAPITAL MANAGEMENT, LLC 405,578$1,091,1240.00%
STATE STREET CORP 368,660$991,6950.00%
PRICE T ROWE ASSOCIATES INC /MD/ 1,216,500$3,2730.00%
NEW YORK STATE COMMON RETIREMENT FUND 9,606$260.00%
STRS OHIO 2,700$70.00%
DEUTSCHE BANK AG\ 870$2,3400.00%
CITIGROUP INC 15$400.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 56,203$151,1860.00%
MORGAN STANLEY 38,570$103,7530.00%
AMALGAMATED BANK 1,796$50.00%
BlackRock Inc. 1,340,480$3,605,8910.00%
Bank of New York Mellon Corp 59,553$160,1980.00%
Nuveen Asset Management, LLC 81,898$779,6680.00%
TWO SIGMA ADVISERS, LP 12,200$32,8180.00%

This page lists THESEUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view THESEUS PHARMACEUTICALS INC's shareholder history, click here.